Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay

Leukemia Research

Volumn 32, Issue 7, 2008, Pages 1036-1042

  Tanaka, Makito ^a   Takahashi, Yoshiyuki ^a   Xu, YinYan ^a   Yoshida, Nao ^a   Yoshimi, Ayami ^b   Villalobos, Itzel Bustos ^a   Hama, Asahito ^a   Nishio, Nobuhiro ^a   Hidaka, Hirokazu ^a   Wang, Yue ^a   Yagasaki, Hiroshi ^a   Kojima, Seiji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3H thymidine assay; Colony forming unit granulocyte macrophage (CFU GM); Granulocyte macrophage colony stimulating factor (GM CSF); Hypersensitivity; Juvenile myelomonocytic leukemia (JMML); PTPN11 mutation; RAS mutation

Indexed keywords

GENOMIC DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE MUTATION; HUMAN; HYPERSENSITIVITY; JUVENILE MYELOMONOCYTIC LEUKEMIA; MALE; MUTATIONAL ANALYSIS; ONCOGENE RAS; PRIORITY JOURNAL; PTPN11 GENE; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; CHILD, PRESCHOOL; FEMALE; GENES, RAS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFANT; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; MALE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; THYMIDINE;

EID: 41949113836     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.11.016     Document Type: Article

References (29)

1. Emanuel P.D. Juvenile myelomonocytic leukemia. Curr Hematol Rep 3 (2004) 203-209
2. Arico M., Biondi A., and Pui C.H. Juvenile myelomonocytic leukemia. Blood 90 (1997) 479-488
3. Niemeyer C.M., Arico M., Basso G., Biondi A., Cantu Rajnoldi A., Creutzig U., et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 89 (1997) 3534-3543
4. Sasaki H., Manabe A., Kojima S., Tsuchida M., Hayashi Y., Ikuta K., et al. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia 15 (2001) 1713-1720
5. Manabe A., Okamura J., Yumura-Yagi K., Akiyama Y., Sako M., Uchiyama H., et al. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group. Leukemia 16 (2002) 645-649
6. Woods W.G., Barnard D.R., Alonzo T.A., Buckley J.D., Kobrinsky N., Arthur D.C., et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. J Clin Oncol 20 (2002) 434-440
7. Locatelli F., Nollke P., Zecca M., Korthof E., Lanino E., Peters C., et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 105 (2005) 410-419
8. Side L.E., Emanuel P.D., Taylor B., Franklin J., Thompson P., Castleberry R.P., et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 92 (1998) 267-272
9. Flotho C., Valcamonica S., Mach-Pascual S., Schmahl G., Corral L., Ritterbach J., et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 13 (1999) 32-37
10. Tartaglia M., Niemeyer C.M., Fragale A., Song X., Buechner J., Jung A., et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34 (2003) 148-150
11. + cells: aberrant growth and differentiation properties. Stem Cells 14 (1996) 690-701
12. Sawai N., Koike K., Ito S., Okumura N., Kamijo T., Shiohara M., et al. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture. Exp Hematol 24 (1996) 116-122
13. Niemeyer C.M., Fenu S., Hasle H., Mann G., Stary J., and van Wering E. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 91 (1998) 365-367
14. Noonan J.A. Noonan syndrome: an update and review for the primary pediatrician. Clin Pediatr (Phila) 33 (1994) 548-555
15. Gelb B.D., and Tartaglia M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum Mol Genet 15 Spec. no. 2 (2006) R220-R226
16. Mitani K., Hangaishi A., Imamura N., Miyagawa K., Ogawa S., Kanda Y., et al. No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes. Leukemia 11 (1997) 863-865
17. Yamamoto T., Isomura M., Xu Y., Liang J., Yagasaki H., Kamachi Y., et al. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukaemia. Leuk Res 30 (2006) 1085-1089
18. Garby L., and Vuille J.C. Studies on erythro-kinetics in infancy. I. A modified one-minute alkali denaturation-precipitation method for haemoglobin F determination: agreement with spectrophotometric method. Acta Paediatr 51 (1962) 197-200
19. Altman A.J., Palmer C.G., and Baehner R.L. Juvenille "chronic granulocytic" leukemia: a panmyelopathy with prominent monocytic involvement and circulating monocyte colony-forming cells. Blood 43 (1974) 341-350
20. Altman A.J., and Baehner R.L. In vitro colony-forming characteristics of chronic granulocytic leukemia in childhood. J Pediatr 86 (1975) 221-224
21. Estrov Z., Grunberger T., Chan H.S., and Freedman M.H. Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures. Blood 67 (1986) 1382-1387
22. Estrov Z., Zimmerman B., Grunberger T., Chao J., Teshima I.E., Chan H.S., et al. Characterization of malignant peripheral blood cells of juvenile chronic myelogenous leukemia. Cancer Res 46 (1986) 6456-6461
23. Geissler K., Hinterberger W., Bettelheim P., Haas O., and Lechner K. Colony growth characteristics in chronic myelomonocytic leukemia. Leuk Res 12 (1988) 373-377
24. Gualtieri R.J., Emanuel P.D., Zuckerman K.S., Martin G., Clark S.C., Shadduck R.K., et al. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia. Blood 74 (1989) 2360-2367
25. Emanuel P.D., Bates L.J., Castleberry R.P., Gualtieri R.J., and Zuckerman K.S. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77 (1991) 925-929
26. Iversen P.O., Lewis I.D., Turczynowicz S., Hasle H., Niemeyer C., Schmiegelow K., et al. Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice. Blood 90 (1997) 4910-4917
27. Yoshida N., Yagasaki H., Xu Y., Tanaka M., Nishio N., Hidaka H., et al. Correlation of clinical features with mutational status in children with juvenile myelomonocytic leukemia. Blood 108 (2006) 2687
28. Matsuda K., Shimada A., Yoshida N., Ogawa A., Watanabe A., Yajima S., et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood 109 (2007) 5477-5480
29. Flotho C., Kratz C., and Niemeyer C.M. Targeting RAS signaling pathways in juvenile myelomonocytic leukemia. Curr Drug Targets 8 (2007) 715-725